Webinar Date/Time: Wed, Jul 23, 2025 11:00 AM EDT
Join Ecolab Life Sciences to explore the newest AP+ chromatography resin, engineered for high performance, speed to market, and sustainable efficiency in biopharma purification.
Register Free: https://globalmeet.webcasts.com/starthere.jsp?ei=1724530&tp_key=4dfcd66142&sti=mjhwebad
Event Overview:
There are many factors to consider when selecting a chromatography resin for use in a biopharmaceutical purification process. No longer does a singular affinity solution address the needs of increasing molecular complexities, cost, time pressures, and operating sustainably. Building on the success of the Purolite™ AP+ resin portfolio, Ecolab is excited to add the latest AP+ resin innovation to its toolbox, where economic efficiencies, acceleration to market, and optimized performance are in focus. The newest purification tool offers high binding capacity, resolution, and stability to optimize your purification process.
Key Learning Objectives:
Who Should Attend:
Featured Speakers:
Benjamin Summers, PhD
Principal Scientist
Ecolab Life Sciences
Benjamin Summers, PhD, received his doctoral degree from the University of York in Chemistry in 2014 studying the production, purification and industrial application of Baeyer-Villiger monooxygenases in partnership with Dr Reddy's Laboratories. Since 2016, Summers has applied his broad experience in chemistry, biology, and biotechnology within Ecolab's Purolite™ Resins applications team to support the development of new chromatographic resins and assist a wide range of customers in developing their downstream bioprocessing solutions as a chromatography expert. In his role, Summers has enjoyed the challenges of solving complex purification processes across varied fields, including biotherapeutics, food and beverage, biocatalysis, and more.
Speaker's Email: ben.summers@ecolab.com
Speaker's LinkedIn: Benjamin Summers
Register Free: https://globalmeet.webcasts.com/starthere.jsp?ei=1724530&tp_key=4dfcd66142&sti=mjhwebad
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.